Syndetics cover image
Image from Syndetics

Roche and Tamiflu® : doing business in the shadow of pandemic / Timothy J. Feddersen, Jochen Gottschalk, Lars Peters.

By: Contributor(s): Material type: TextSeries: Publisher: London : Kellogg School of Management, 2007Description: 1 online resource : illustrationsContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781526449092 (ebook) :
Subject(s): DDC classification:
  • 615.372 23
Online resources: The Tamiflu case puts students in the uncomfortable position of Hoffmann-La Roche, a pharmaceutical company which owns a key antiviral drug Tamiful that if taken within 48 hours of infection from the new H5N1 virus or bird flu dramatically increases the chances of survival. Students are forced to weigh the benefits of short-term profit maximization against the probability that a highly uncertain event could impact the business severely through nonmarket dynamics.
No physical items for this record

Originally published in Feddersen, T. J., Gottschalk, J., & Peters, L. (2007). Roche and Tamiflu®: Doing business in the shadow of pandemic. 5-107-010. Evanston, IL: Kellogg School of Management at Northwestern University.

The Tamiflu case puts students in the uncomfortable position of Hoffmann-La Roche, a pharmaceutical company which owns a key antiviral drug Tamiful that if taken within 48 hours of infection from the new H5N1 virus or bird flu dramatically increases the chances of survival. Students are forced to weigh the benefits of short-term profit maximization against the probability that a highly uncertain event could impact the business severely through nonmarket dynamics.

Description based on XML content.

Licensed e-book